A sequential injection method for the determination of piroxicam in pharmaceutical formulations using europium sensitized fluorescence

被引:37
作者
Al-Kindy, SMZ [1 ]
Al-Wishahi, A [1 ]
Suliman, FEO [1 ]
机构
[1] Sultan Qaboos Univ, Coll Sci, Dept Chem, Al Khoud 123, Oman
关键词
sensitized fluorescence; europium; piroxicam; sequential injection;
D O I
10.1016/j.talanta.2004.04.014
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A simple, selective and sensitive luminescence method for the assay of piroxicam (PX) in pharmaceutical formulation is developed. The method is based on the luminescence sensitization of europium (Eu3+) by complexation with PX. The signal for PX-EU is monitored at lambda(ex) = 358 nm and lambda(em) = 615 nm. Optimum conditions for the formation of the complex in methanol were 0.01 M TRIS buffer and 0.2 mM of Eu3+ which allows the determination of 100-2000 ppb of pX in batch method and 100-1000 ppb with limit of detection (LOD) = 23.0 ppb using sequential injection analysis (SIA). The relative standard deviations of the method range between 2 and 3% indicating excellent reproducibility of the method. The proposed method was successfully applied for he assay of PX in pharmaceutical formulations (Feldene capsules and tablets). Average recoveries of 101.0 +/- 0.3 and 98.8 +/- 2.7% were obtained for capsules in methanol using batch and sequential injection (SI) methods, respectively. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:1343 / 1350
页数:8
相关论文
共 28 条
[1]   Spectrophotometric determination of piroxicam and tenoxicam in pharmaceutical formulations using alizarin [J].
Amin, AS .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 29 (04) :729-736
[2]   Two different strategies for the fluorimetric determination of piroxicam in serum [J].
Arancibia, JA ;
Escandar, GM .
TALANTA, 2003, 60 (06) :1113-1121
[3]   Sensitive detection of tetracyclines using europium-sensitized fluorescence with EDTA as co-ligand and cetyltrimethylammonium chloride as surfactant [J].
Arnaud, N ;
Georges, J .
ANALYST, 2001, 126 (05) :694-697
[4]   Spectroscopic studies of micro environment dictated structural forms of piroxicam and meloxicam [J].
Banerjee, R ;
Sarkar, M .
JOURNAL OF LUMINESCENCE, 2002, 99 (03) :255-263
[5]   Incorporation of NSAIDs in micelles: implication of structural switchover in drug-membrane interaction [J].
Chakraborty, H ;
Banerjee, R ;
Sarkar, M .
BIOPHYSICAL CHEMISTRY, 2003, 104 (01) :315-325
[6]   COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression [J].
Chandrasekharan, NV ;
Dai, H ;
Roos, KLT ;
Evanson, NK ;
Tomsik, J ;
Elton, TS ;
Simmons, DL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (21) :13926-13931
[7]   LC determination of piroxicam in human plasma [J].
Dadashzadeh, S ;
Vali, AM ;
Rezagholi, N .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 28 (06) :1201-1204
[8]  
El-Ries MA, 1998, ANAL LETT, V31, P793
[9]  
ELMAALI NA, 1989, ANAL LETT, V22, P3025
[10]   Spectrofluorimetric determination of piroxicam in the presence and absence of β-cyclodextrin [J].
Escandar, GM .
ANALYST, 1999, 124 (04) :587-591